Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2750 of 2873 entries
View as:

Expanded Natural Killer Cell Infusion in Treating Younger Patients With Recurrent/Refractory Brain Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02271711 Org: User:
Start: 03/17/15 End: 08/28/20 Due: 08/28/21

Omacetaxine and Venetoclax for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Harboring Mutant RUNX1

Phase: N/A Priority: Normal
NCT ID: NCT04874194 Org: User:
Start: 12/17/21 End: 09/16/24 Due: 09/16/25

Bioelectrical Impedance Analysis in Estimating Body Composition in Patients With Stage I-IV Head and Neck Cancer Undergoing Radiation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02615275 Org: User:
Start: 11/24/15 End: 11/30/26 Due: 11/30/27

A Randomized Phase II Basket Trial EXTENDing Efficacy of Systemic Therapy with Local Consolidative Therapy for OligoProgressive Metastatic Disease (EXTEND-OP)

Phase: N/A Priority: Normal
NCT ID: NCT06367972 Org: User:
Start: 06/06/24 End: 10/10/30 Due: 10/10/31

Clofarabine, Idarubicin, and Cytarabine Combination in Acute Myeloid Leukemia (AML) Induction

Phase: N/A Priority: Normal
NCT ID: NCT01025154 Org: User:
Start: 01/31/10 End: 02/28/13 Due: 02/28/14

Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03830151 Org: User:
Start: 05/16/19 End: 12/31/25 Due: 12/31/26

A Comprehensive Clinical fMRI Software Solution to Enable Mapping of Critical Functional Networks and Cerebrovascular Reactivity in the Brain

Phase: N/A Priority: Normal
NCT ID: NCT05342454 Org: User:
Start: 05/23/22 End: 11/30/26 Due: 11/30/27

Occupational Therapy in Palliative Care

Phase: N/A Priority: Normal
NCT ID: NCT02521194 Org: User:
Start: 11/13/15 End: 01/05/20 Due: 01/05/21

High Dose I-131 Metaiodobenzylguanidine(MIBG) for Metastatic Neuroendocrine Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00037869 Org: User:
Start: 11/30/01 End: 01/31/05 Due: 01/31/06

Phase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in Localized Esophageal and Gastroesophageal Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03784326 Org: User:
Start: 02/19/19 End: 12/31/26 Due: 12/31/27

Dose Escalation and Cohort Expansion of Safety and Tolerability Study of Intratumoral rAd.CD40L (ISF35) in Combination of Systemic Pembrolizumab in Patients With Refractory Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT02719015 Org: User:
Start: 03/31/18 End: 03/31/22 Due: 03/31/23

T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy (attIL12-TIL) for Advanced/Metastatic Soft Tissue and Bone Sarcoma Patients.

Phase: N/A Priority: Normal
NCT ID: NCT06474676 Org: User:
Start: 09/30/25 End: 12/31/32 Due: 12/31/33

Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response in Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03581500 Org: User:
Start: 02/06/19 End: 10/16/24 Due: 10/16/25

Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00338377 Org: User:
Start: 02/01/06 End: 02/28/30 Due: 02/28/31

Social Determinants and Smoking Cessation

Phase: N/A Priority: Normal
NCT ID: NCT01310842 Org: User:
Start: 07/31/12 End: 09/30/16 Due: 09/30/17

Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management

Phase: N/A Priority: Normal
NCT ID: NCT04216732 Org: User:
Start: 01/10/20 End: 09/01/26 Due: 09/01/27

iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation

Phase: N/A Priority: Normal
NCT ID: NCT03608631 Org: User:
Start: 01/27/21 End: 04/30/27 Due: 04/30/28

ONC201 in Treating Patients With Relapsed or Refractory Acute Leukemia or High-Risk Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT02392572 Org: User:
Start: 11/03/15 End: 11/30/26 Due: 11/30/27

Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Metastatic Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02092298 Org: User:
Start: 05/08/14 End: 05/12/20 Due: 05/12/21

Rocking Motion: Physiologic Effect on the Surgical Stress Response

Phase: N/A Priority: Normal
NCT ID: NCT01200316 Org: User:
Start: 02/01/12 End: 11/20/17 Due: 11/20/18

HEALTH4CLL2: A Randomized Waitlist Control Trial of Behavioral Interventions in Patients With Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT05879133 Org: User:
Start: 05/17/23 End: 07/03/25 Due: 07/03/26

Preoperative and Postoperative Imatinib Mesylate Study in Patients With c-Kit Positive GIST

Phase: N/A Priority: Normal
NCT ID: NCT00500188 Org: User:
Start: 07/31/03 End: 07/31/11 Due: 07/31/12

Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04479696 Org: User:
Start: 06/05/19 End: 02/02/27 Due: 02/02/28

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT03136146 Org: User:
Start: 08/09/17 End: 08/01/26 Due: 08/01/27

Neuromodulation as a Treatment for Chemotherapy-Induced Peripheral Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT02573766 Org: User:
Start: 10/01/15 End: 10/01/26 Due: 10/01/27